Lv1
20 积分 2025-07-11 加入
Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity
1小时前
待确认
IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control
1小时前
已完结
Dictionary of immune responses to cytokines at single-cell resolution
2小时前
已完结
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
14天前
已完结
IL-2 Induces Conformational Changes in Its Preassembled Receptor Core, Which Then Migrates in Lipid Raft and Binds to the Cytoskeleton Meshwork
19天前
已完结
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
1个月前
已完结
The IL-4, IL-13 and IL-31 pathways in atopic dermatitis
1个月前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
2个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
2个月前
已完结
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
3个月前
已完结
皖公网安备34019202002308
